AGP Executive Report
Last update: 10 hours agoMENA Biotech Deal: Ocugen signed a binding term sheet to license its OCU400 modifier gene therapy for retinitis pigmentosa across the Middle East and North Africa, with up to $4m in upfront/near-term payments, as well as sales milestones up to $255m and a 22% royalty, plus manufacturing supply via a partner. UAE Startup Pipeline: Dubai opened applications for an Emirati founders incubator inside Dubai Founders HQ, aiming to take early ideas through market validation and product readiness, with continued access to mentors, investors and corporate partners. Abu Dhabi Business Momentum: Abu Dhabi reported strong Q1 business formation momentum, with professional licenses up 193% and commercial licenses up 20%, alongside growth in agriculture, fisheries and livestock licensing. Saudi Private Credit Push: Gemcorp says it plans to raise $1bn funds from Abu Dhabi and $1bn in Saudi Arabia, targeting deals in mining/rare earths, tech and social infrastructure like schools and hospitals. Israel Cyber Shift: A former IDF cyber executive warned that Iran-linked cyberattacks on Israel are still escalating even as kinetic fighting pauses, with infrastructure defense running behind the scenes—an issue that matters for SMBs reliant on stable systems. SME IPO Watch (India): Millworks Technologies’ BSE SME IPO opens July 14, with grey-market GMP suggesting a potential 100%+ listing pop, highlighting continued appetite for smaller-company listings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.